Press Enter to search · ESC to close

Regulation

Hyperliquid Policy Center Backs CFTC in CME Lawsuit Over Kalshi Crypto Perpetuals

Hyperliquid Policy Center filed an amicus brief supporting the CFTC in CME's lawsuit over Kalshi's crypto perpetual contracts. The outcome could shape the regulatory landscape for crypto derivatives in the U.S.

Hyperliquid Policy Center Files Amicus Brief Supporting CFTC Against CME

On September 10, Hyperliquid Policy Center submitted a legal brief to the U.S. District Court for the District of Columbia, urging the court to dismiss a lawsuit filed by Chicago Mercantile Exchange (CME) against the Commodity Futures Trading Commission (CFTC). The lawsuit challenges the CFTC’s approval of Kalshi to offer regulated cryptocurrency perpetual contracts in the United States.

Hyperliquid Policy Center, the advocacy arm of the Hyperliquid ecosystem, has taken the side of the CFTC, arguing that CME’s legal action is without merit and should be rejected. The filing marks a notable intervention by a decentralized exchange (DEX) player in a regulatory dispute that pits a traditional derivatives giant against a federal regulator.

Industry Analysis

This legal battle is more than a procedural spat—it underscores the growing tension between incumbent financial institutions and emerging crypto-native platforms. CME’s lawsuit appears to be a defensive move to protect its dominant position in the derivatives market, as Kalshi’s approval could open the door for more crypto perpetual contracts under CFTC oversight, potentially eroding CME’s market share.

Hyperliquid’s support for the CFTC is strategic. As a leading decentralized perpetuals exchange, Hyperliquid has a vested interest in a regulatory environment that permits innovative trading venues to operate without undue restriction. By backing the CFTC, Hyperliquid positions itself as a pro-regulation advocate, while simultaneously challenging the traditional financial establishment’s attempts to stifle competition.

The outcome of this case could set a precedent for how crypto derivatives are regulated in the U.S. If the court dismisses CME’s lawsuit, it would affirm the CFTC’s authority to approve new types of crypto products, potentially accelerating the entry of more digital asset derivatives into regulated markets. Conversely, a ruling in favor of CME could slow down the approval process and create uncertainty for platforms like Kalshi and Hyperliquid.

Forward-Looking Perspective

As the case progresses, market participants should watch for signals from the court regarding the scope of the CFTC’s regulatory discretion. A favorable ruling for the CFTC could bolster confidence in the U.S. regulatory framework for crypto derivatives, attracting more institutional participation. Hyperliquid’s involvement also highlights the growing influence of DeFi entities in shaping policy—a trend likely to continue as decentralized platforms gain mainstream traction.

In the near term, this legal skirmish may not directly impact the price of crypto assets, but it reflects the ongoing battle for market structure dominance. Traditional exchanges like CME are fighting to retain their foothold, while crypto-native firms are pushing for a more inclusive regulatory landscape. The court’s decision will be a bellwether for the future of crypto derivatives regulation in the United States.

View original

Share
Risk notice This site provides news and information on the crypto, blockchain and Web3 industry for reference only and does not constitute investment advice or any promise of returns. Virtual currency-related activities are illegal financial activities in mainland China; digital asset prices are highly volatile; use at your own risk. This site does not provide trading, token issuance or related referral services.

Related Reading

Latest News

TREE NEWS share card
Long-press image above → Save to Photos / Share
Pitch us Feedback